Back to News
Market Impact: 0.2
Chugai Pharmaceutical Co., - Depositary Receipt Price Target Decreased by 15.22% to $26.89
Source: Nasdaq
Analyst EstimatesAnalyst Insights
The average one-year price target for Chugai Pharmaceutical Co. depositary receipts was revised down 15.22% to $26.89 per share from $31.72 on June 8, 2026. The figures represent aggregate analyst targets; no share-price reaction or other company news was reported.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
More News
- SpaceX bear flips to big bull because of AI business. Analyst now sees 70% gain
- Williams Trading cuts Deckers Outdoor stock price target on weak DTC trends
- Jefferies raises Zymeworks stock price target on Roche deal
- Truist raises United Rentals stock price target on strong margins
- Century Casinos receives Nasdaq notice for minimum market value deficiency
- GM stock analysis: cheap valuation meets falling estimates after earnings drop